H
Health Catalyst, Inc. (HCAT)
NMS – Real Time Price. Currency in USD
1.48
+0.10 (7.25%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
1.48
+0.10 (7.25%)
At close: May 12, 2026, 4:00 PM EDT
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. The company operates in two segments: Technology and Professional Services. It offers ignite data and analytics platform that provides clients a single comprehensive environment to integrate and organize data from their disparate software systems; and applications, a software analytics applications build for ignite platform to analyze clients face across clinical improvement, revenue and cost improvement, ambulatory operations, measures and registries, and data and analytics. The company also provides expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. It serves academic medical centers, integrated delivery networks, community hospitals, large physician practices, accountable care organizations, health information exchanges, health insurers, life science organizations, healthcare technology vendors, and other risk-bearing entities. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.
| Name | Position |
|---|---|
| Mr. Benjamin Albert | CEO & Director |
| Mr. Benjamin Landry | General Counsel & Secretary of the Board |
| Mr. Jason Alger | Chief Financial Officer |
| Mr. Jeffrey P. Selander | Senior Vice President of International |
| Mr. Kyle J. Salyers | Chief Strategy Officer & Senior VP of Corporate Development |
| Ms. Carrie Kozlowski OT | Chief Marketing Officer |
| Ms. Cathy R. Menkiena B.S.N., M.B.A., R.N. | Senior VP & GM of Strategic Accounts, North America |
| Ms. Holly Rimmasch | Senior VP & Chief Clinical Officer |
| Ms. Linda Llewelyn | Chief People Officer |
| Ms. Sadiqa Mahmood D.D.S., M.P.H. | GM & Senior VP of Life Sciences Business |
| Date | Type | Document |
|---|---|---|
| 2026-04-30 | 8-K | hcat-20260429.htm |
| 2026-04-30 | 10-K/A | hcat-20251231.htm |
| 2026-04-27 | 8-K | hcat-20260424.htm |
| 2026-04-03 | 8-K | hcat-20260331.htm |
| 2026-03-12 | 10-K | hcat-20251231.htm |
| 2026-02-18 | 8-K | hcat-20260212.htm |
| 2026-01-23 | 8-K | hcat-20260120.htm |
| 2026-01-12 | 8-K | hcat-20260112.htm |
| 2025-12-02 | 8-K | hcat-20251201.htm |
| 2025-11-10 | 10-Q | hcat-20250930.htm |